Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrara

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Current Oncology (Toronto, Ont.)|May 27, 2022
Genomics and Immunomics in the Treatment of Urothelial CarcinomaVeronica Mollica, Francesco Massari, Alessandro Rizzo, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Is hyperprogressive disease a specific phenomenom of immunotherapy?Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, et al.
Chirurgia Italiana|November 21, 2007
Abdominal incisional hernia repair. Intraperitoneal prosthetic technique using Bard Kugel Composix MeshRoberto Ferrara, Sandro Imperiale, Romano Polato, et al.
Nature Reviews. Clinical Oncology|October 27, 2018
Hyperprogressive disease: recognizing a novel pattern to improve patient managementStéphane Champiat, Roberto Ferrara, Christophe Massard, et al.
Nature Reviews. Clinical Oncology|August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?Martin Reck, Nikolaj Frost, Solange Peters, et al.
The Cochrane Database of Systematic Reviews|April 30, 2021
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancerRoberto Ferrara, Martina Imbimbo, Reem Malouf, et al.
Entropy (Basel, Switzerland)|September 28, 2023
Quantum and Quantum-Inspired Stereographic K Nearest-Neighbour ClusteringAlonso Viladomat Jasso, Ark Modi, Roberto Ferrara, et al.
The Cochrane Database of Systematic Reviews|December 14, 2020
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancerRoberto Ferrara, Martina Imbimbo, Reem Malouf, et al.
European Journal of Ophthalmology|July 20, 2010
Quality of Vision Index: a new method to appraise visual function changes in age-related macular degenerationStefano Piermarocchi, Monica Varano, Mariacristina Parravano, et al.
The Cochrane Database of Systematic Reviews|May 27, 2025
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutationMario Occhipinti, Martina Imbimbo, Roberto Ferrara, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Current Oncology (Toronto, Ont.)|May 27, 2022
Genomics and Immunomics in the Treatment of Urothelial CarcinomaVeronica Mollica, Francesco Massari, Alessandro Rizzo, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Is hyperprogressive disease a specific phenomenom of immunotherapy?Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, et al.
Chirurgia Italiana|November 21, 2007
Abdominal incisional hernia repair. Intraperitoneal prosthetic technique using Bard Kugel Composix MeshRoberto Ferrara, Sandro Imperiale, Romano Polato, et al.
Nature Reviews. Clinical Oncology|October 27, 2018
Hyperprogressive disease: recognizing a novel pattern to improve patient managementStéphane Champiat, Roberto Ferrara, Christophe Massard, et al.
Nature Reviews. Clinical Oncology|August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?Martin Reck, Nikolaj Frost, Solange Peters, et al.
The Cochrane Database of Systematic Reviews|April 30, 2021
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancerRoberto Ferrara, Martina Imbimbo, Reem Malouf, et al.
Entropy (Basel, Switzerland)|September 28, 2023
Quantum and Quantum-Inspired Stereographic K Nearest-Neighbour ClusteringAlonso Viladomat Jasso, Ark Modi, Roberto Ferrara, et al.
The Cochrane Database of Systematic Reviews|December 14, 2020
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancerRoberto Ferrara, Martina Imbimbo, Reem Malouf, et al.
European Journal of Ophthalmology|July 20, 2010
Quality of Vision Index: a new method to appraise visual function changes in age-related macular degenerationStefano Piermarocchi, Monica Varano, Mariacristina Parravano, et al.
The Cochrane Database of Systematic Reviews|May 27, 2025
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutationMario Occhipinti, Martina Imbimbo, Roberto Ferrara, et al.
Pageof 15